Research Article
Effect of Exercise Training on Interleukin-6, Tumour Necrosis Factor Alpha and Functional Capacity in Heart Failure
Table 2
Clinical characteristics and pharmacotherapy of the 106 patients.
| | Clinical characteristics | |
| | Age (Years) | 61.8 ± 9.9 | | Male (%) | 98 (92.5) | | Body mass (kg) | 78.7 ± 13.7 | | Peak VO2 (ml·kg−1·min−1) | 16.9 ± 4.4 | | Diabetes (%) | 11 (10) | | Previous myocardial infarction (%) | 86 (81) | | Atrial fibrillation (%) | 27 (26) | | NYHA class II/III | 49/57 | | LVEF (%) | 30 ± 6.9 |
| | Medications | |
| | Beta-blocker (%) | 44 (42) | | ACE-inhibitor/antagonist (%) | 95 (90) | | Digoxin (%) | 67 (63) | | Nitrates (%) | 40 (38) |
|
|
